Literature DB >> 9217880

Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased.

D Feuvray1, G D Lopaschuk.   

Abstract

Controversy exists as to whether the diabetic heart is more or less sensitive to ischemic injury. Although a considerable number of experimental studies have directly determined the effects of ischemia on the diabetic heart, there is still no general agreement as to whether metabolic changes within the myocardium contribute to the severity of ischemic injury. This paper reviews the evidence suggesting that the diabetic heart can actually be less sensitive to an episode of severe ischemia. Possible reasons for this decreased sensitivity to injury are discussed, which include a decreased accumulation of glycolytic products during ischemia (lactate and protons), as well as alterations in the regulation of intracellular pH in the diabetic heart. Based on existing studies, we suggest that although impaired glucose metabolism in the diabetic heart contributes to injury in hypoxic hearts or in hearts subjected to low-flow ischemia, diabetes-induced decreases in glycolysis can actually be beneficial to the diabetic heart during and following a severe ischemic episode. A decreased clearance of protons via the Na+/H+ exchanger may also contribute to the decreased sensitivity to ischemic injury in the diabetic heart.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217880     DOI: 10.1016/s0008-6363(97)00037-0

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  34 in total

1.  Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.

Authors:  T L Broderick; W Driedzic; D J Paulson
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

Review 2.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

Review 3.  Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.

Authors:  Aslan T Turer; Joseph A Hill
Journal:  Am J Cardiol       Date:  2010-08-01       Impact factor: 2.778

Review 4.  Cardiovascular autonomic neuropathies as complications of diabetes mellitus.

Authors:  Michael Kuehl; Martin J Stevens
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

5.  Is hyperglycemia bad for the heart during acute ischemia?

Authors:  Louis M Chu; Robert M Osipov; Michael P Robich; Jun Feng; Shizu Oyamada; Cesario Bianchi; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2010-06-12       Impact factor: 5.209

6.  Impaired cytosolic NADH shuttling and elevated UCP3 contribute to inefficient citric acid cycle flux support of postischemic cardiac work in diabetic hearts.

Authors:  Natasha H Banke; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2014-11-05       Impact factor: 5.000

7.  Subcellular mechanisms of adaptation in the diabetic myocardium: Relevance to ischemic preconditioning in the nondiseased heart.

Authors:  T Ravingerová; A Adameová; J Matejíková; T Kelly; M Nemčeková; J Kucharská; O Pecháňová; A Lazou
Journal:  Exp Clin Cardiol       Date:  2010

8.  Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.

Authors:  G Wölkart; X Pang; H Stessel; M Kirchengast; F Brunner
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

9.  Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto-Kakizaki rat.

Authors:  Dario Loureiro Santos; Carlos Marques Palmeira; Raquel Seiça; José Dias; José Mesquita; António Joaquim Moreno; Maria Sancha Santos
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

10.  Targeted Modification of Mitochondrial ROS Production Converts High Glucose-Induced Cytotoxicity to Cytoprotection: Effects on Anesthetic Preconditioning.

Authors:  Filip Sedlic; Maria Y Muravyeva; Ana Sepac; Marija Sedlic; Anna Marie Williams; Meiying Yang; Xiaowen Bai; Zeljko J Bosnjak
Journal:  J Cell Physiol       Date:  2016-06-21       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.